The document outlines the Coverage Gap Discount Program (CGDP) created by the Affordable Care Act to assist Medicare Part D beneficiaries by providing discounts on prescription drugs within the coverage gap, aiming to eliminate the gap by 2020. It discusses operational, financial, compliance, and legal challenges faced by manufacturers under the CGDP, alongside practical solutions for effective program management. Key points include the importance of data management, dispute resolution processes, and negotiating terms with Part D plans to mitigate financial risks and improve forecasting capabilities.
Related topics: